SOST and osteoporosis: The study by Battaglino et al. found that serum sclerostin levels increased in the acute and short-term SCI (<5 years post SCI) and then decreased with the chronicity of the disease, proposing that sclerostin can be used as a marker of osteoporosis severity in SCI [26].